ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Phoenix, AZ, USA:

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Active, not recruiting
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

Phase 2

Cyanvac

Phoenix, Arizona, United States and 54 other locations

States. The purpose of the study is to assess the safety and immunogenicity of recombinant influenza vaccine (RIV) + adjuvanted recombinant COVID...

Active, not recruiting
COVID-19 Immunization
Influenza Immunization
Biological: RIV + rC19 (dose 3)
Biological: RIV + rC19 (dose 2)

Phase 1, Phase 2

Sanofi
Sanofi

Phoenix, Arizona, United States and 11 other locations

tissue derived mesenchymal stem cells (AdMSC), in patients with COVID-19 pneumonia. After each subject completes 12-Weeks visit (Vi...

Enrolling
Covid19 Pneumonia
Drug: AstroStem-V

Phase 1, Phase 2

Nature Cell

Phoenix, Arizona, United States and 1 other location

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Phoenix, Arizona, United States and 144 other locations

Locations recently updated

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Phoenix, Arizona, United States and 215 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Phoenix, Arizona, United States and 74 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Phoenix, Arizona, United States and 122 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Phoenix, Arizona, United States and 33 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Enrolling
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Phoenix, Arizona, United States and 149 other locations

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

Phoenix, Arizona, United States and 205 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems